Share Price and Basic Stock Data
Last Updated: January 12, 2026, 11:59 am
| PEG Ratio | 4.21 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bannari Amman Sugars Ltd operates in the sugar industry, with its stock currently priced at ₹3,600 and a market capitalization of ₹4,537 Cr. The company reported a total revenue of ₹2,526 Cr for the financial year ending March 2023, representing a notable increase from ₹1,998 Cr in the previous year. However, the revenue is projected to decline to ₹1,793 Cr for FY 2025. Quarterly sales figures depict fluctuations, with the latest quarter (September 2023) recording sales of ₹600 Cr, a decrease from ₹932 Cr in December 2022. The operating profit margin (OPM) has shown variability, standing at 13% in FY 2025, which is consistent with the typical sector range but lower than the 16% recorded in December 2023. The company has faced challenges in maintaining consistent revenue growth, illustrating the volatility in the sugar market influenced by factors such as weather conditions and government policies.
Profitability and Efficiency Metrics
The profitability metrics of Bannari Amman Sugars reflect a mixed performance. The net profit for the financial year ending March 2023 stood at ₹143 Cr, a substantial increase from ₹80 Cr in FY 2022. However, this is projected to decline to ₹105 Cr for FY 2025. The return on equity (ROE) stood at 6.04%, while the return on capital employed (ROCE) was reported at 8.68%, indicating moderate efficiency compared to industry norms. The interest coverage ratio (ICR) remains strong at 14.99x, suggesting the company is well-positioned to meet its interest obligations. The cash conversion cycle (CCC) was reported at 263 days, which is relatively high and indicates a slower turnover of inventory and receivables. This extended cycle could potentially strain liquidity in times of financial stress, impacting operational efficiency.
Balance Sheet Strength and Financial Ratios
Bannari Amman Sugars’ balance sheet exhibits resilience with total assets of ₹2,226 Cr and total liabilities of ₹2,180 Cr as of March 2025. The company has reported reserves of ₹1,809 Cr, indicating a solid equity base, while borrowings have significantly reduced to ₹19 Cr, underscoring a strong de-leveraging trend. The debt-to-equity ratio stands at 0.08, signaling a conservative approach towards leverage, which is favorable compared to typical sector levels. The price-to-book value (P/BV) ratio is recorded at 2.65x, reflecting a premium valuation in the market. Furthermore, the current ratio of 3.33x indicates ample liquidity to cover short-term obligations. However, the low return on equity (ROE) of 5.88% raises concerns regarding the effective utilization of equity capital, which may deter potential investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Bannari Amman Sugars reveals a stable ownership structure, with promoters holding 58.69% of the shares, while public ownership accounts for 41.02%. This significant promoter stake suggests strong management control and commitment to the company’s long-term vision. The presence of foreign institutional investors (FIIs) is minimal at 0.27%, indicating limited foreign interest, which may affect the stock’s liquidity. The number of shareholders has decreased to 7,535 from a peak of 8,766 in December 2023, suggesting some erosion in retail investor confidence. Despite this, the company maintains a consistent dividend payout ratio of around 15%, which reflects a commitment to returning value to shareholders. This stability in dividends can enhance investor confidence, particularly for those seeking income in a volatile market.
Outlook, Risks, and Final Insight
The outlook for Bannari Amman Sugars is characterized by both opportunities and challenges. The company’s strong balance sheet and low debt levels provide a robust foundation for future growth. However, risks such as fluctuations in sugar prices, regulatory changes, and dependence on agricultural output pose significant threats to profitability. Additionally, the projected decline in revenue for FY 2025 raises concerns about the company’s growth trajectory. To navigate these challenges, Bannari Amman Sugars may need to enhance operational efficiencies and diversify its product offerings. The company could also consider strategic partnerships to bolster market presence. Overall, while the fundamentals present a solid base, the management must address the highlighted risks to maintain investor confidence and achieve sustainable growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gayatri Sugars Ltd | 68.8 Cr. | 9.26 | 16.7/7.02 | 246 | 16.8 | 0.00 % | 36.6 % | % | 10.0 |
| Dhampure Speciality Sugars Ltd | 93.3 Cr. | 107 | 118/82.0 | 23.7 | 45.3 | 0.00 % | 11.6 % | 8.88 % | 10.0 |
| Dhampur Bio Organics Ltd | 508 Cr. | 76.5 | 110/57.3 | 297 | 145 | 1.63 % | 3.97 % | 1.56 % | 10.0 |
| DCM Shriram Industries Ltd | 602 Cr. | 46.1 | 63.1/44.9 | 9.87 | 105 | 4.34 % | 13.7 % | 11.8 % | 2.00 |
| Davangere Sugar Company Ltd | 644 Cr. | 4.50 | 12.4/3.03 | 50.9 | 3.52 | 0.00 % | 6.70 % | 3.17 % | 1.00 |
| Industry Average | 1,651.00 Cr | 250.89 | 41.65 | 225.56 | 0.83% | 8.62% | 7.89% | 6.37 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 510 | 932 | 656 | 431 | 600 | 768 | 421 | 404 | 474 | 421 | 494 | 419 | 572 |
| Expenses | 442 | 835 | 553 | 387 | 508 | 649 | 370 | 375 | 406 | 360 | 441 | 382 | 497 |
| Operating Profit | 68 | 98 | 103 | 44 | 92 | 119 | 51 | 29 | 67 | 61 | 53 | 37 | 75 |
| OPM % | 13% | 10% | 16% | 10% | 15% | 16% | 12% | 7% | 14% | 15% | 11% | 9% | 13% |
| Other Income | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 1 | 21 | 4 | 7 |
| Interest | 13 | 13 | 10 | 10 | 7 | 7 | 8 | 6 | 2 | 4 | 3 | 1 | 1 |
| Depreciation | 19 | 19 | 18 | 14 | 14 | 14 | 15 | 14 | 14 | 14 | 16 | 15 | 15 |
| Profit before tax | 38 | 68 | 76 | 20 | 73 | 100 | 31 | 10 | 53 | 45 | 55 | 24 | 66 |
| Tax % | 29% | 40% | 35% | 33% | 33% | 32% | 30% | 35% | 35% | 35% | 36% | 37% | 35% |
| Net Profit | 27 | 41 | 50 | 14 | 49 | 68 | 22 | 6 | 34 | 29 | 35 | 15 | 43 |
| EPS in Rs | 21.48 | 32.58 | 39.81 | 10.84 | 38.92 | 54.28 | 17.41 | 5.13 | 27.33 | 22.98 | 28.04 | 12.16 | 34.05 |
Last Updated: January 2, 2026, 7:31 am
Below is a detailed analysis of the quarterly data for Bannari Amman Sugars Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 572.00 Cr.. The value appears strong and on an upward trend. It has increased from 419.00 Cr. (Jun 2025) to 572.00 Cr., marking an increase of 153.00 Cr..
- For Expenses, as of Sep 2025, the value is 497.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 382.00 Cr. (Jun 2025) to 497.00 Cr., marking an increase of 115.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Jun 2025) to 75.00 Cr., marking an increase of 38.00 Cr..
- For OPM %, as of Sep 2025, the value is 13.00%. The value appears strong and on an upward trend. It has increased from 9.00% (Jun 2025) to 13.00%, marking an increase of 4.00%.
- For Other Income, as of Sep 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Jun 2025) to 7.00 Cr., marking an increase of 3.00 Cr..
- For Interest, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 15.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 66.00 Cr.. The value appears strong and on an upward trend. It has increased from 24.00 Cr. (Jun 2025) to 66.00 Cr., marking an increase of 42.00 Cr..
- For Tax %, as of Sep 2025, the value is 35.00%. The value appears to be improving (decreasing) as expected. It has decreased from 37.00% (Jun 2025) to 35.00%, marking a decrease of 2.00%.
- For Net Profit, as of Sep 2025, the value is 43.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Jun 2025) to 43.00 Cr., marking an increase of 28.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 34.05. The value appears strong and on an upward trend. It has increased from 12.16 (Jun 2025) to 34.05, marking an increase of 21.89.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:35 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 651 | 930 | 1,456 | 1,752 | 1,481 | 1,125 | 1,609 | 1,563 | 1,998 | 2,526 | 2,220 | 1,793 | 1,906 |
| Expenses | 503 | 802 | 1,251 | 1,404 | 1,270 | 943 | 1,378 | 1,352 | 1,780 | 2,221 | 1,914 | 1,583 | 1,680 |
| Operating Profit | 148 | 128 | 204 | 348 | 211 | 182 | 231 | 211 | 218 | 304 | 306 | 210 | 226 |
| OPM % | 23% | 14% | 14% | 20% | 14% | 16% | 14% | 13% | 11% | 12% | 14% | 12% | 12% |
| Other Income | -2 | 16 | 3 | 6 | 5 | 8 | 4 | 9 | 3 | 39 | 7 | 26 | 34 |
| Interest | 62 | 93 | 116 | 97 | 34 | 30 | 44 | 39 | 32 | 49 | 32 | 16 | 9 |
| Depreciation | 52 | 51 | 62 | 69 | 70 | 67 | 65 | 66 | 68 | 74 | 58 | 59 | 61 |
| Profit before tax | 32 | 0 | 30 | 187 | 112 | 93 | 126 | 115 | 122 | 220 | 224 | 162 | 189 |
| Tax % | 11% | -209% | -7% | 22% | 22% | 18% | 24% | 20% | 34% | 35% | 32% | 35% | |
| Net Profit | 29 | 1 | 32 | 145 | 87 | 76 | 96 | 92 | 80 | 143 | 152 | 105 | 122 |
| EPS in Rs | 25.08 | 0.90 | 27.73 | 115.77 | 69.59 | 60.56 | 76.27 | 73.48 | 63.78 | 114.35 | 121.45 | 83.47 | 97.23 |
| Dividend Payout % | 50% | 278% | 27% | 11% | 14% | 17% | 13% | 14% | 16% | 11% | 10% | 15% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -96.55% | 3100.00% | 353.12% | -40.00% | -12.64% | 26.32% | -4.17% | -13.04% | 78.75% | 6.29% | -30.92% |
| Change in YoY Net Profit Growth (%) | 0.00% | 3196.55% | -2746.88% | -393.12% | 27.36% | 38.96% | -30.48% | -8.88% | 91.79% | -72.46% | -37.21% |
Bannari Amman Sugars Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 2% |
| 3 Years: | -4% |
| TTM: | -18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 64% |
| 5 Years: | 2% |
| 3 Years: | 9% |
| TTM: | -22% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 22% |
| 3 Years: | 9% |
| 1 Year: | 8% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 8% |
| 3 Years: | 8% |
| Last Year: | 6% |
Last Updated: September 5, 2025, 12:35 am
Balance Sheet
Last Updated: December 4, 2025, 1:01 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 943 | 940 | 920 | 1,055 | 1,123 | 1,183 | 1,262 | 1,344 | 1,411 | 1,539 | 1,676 | 1,766 | 1,809 |
| Borrowings | 1,052 | 1,221 | 1,534 | 1,038 | 508 | 769 | 996 | 872 | 961 | 581 | 486 | 150 | 19 |
| Other Liabilities | 274 | 232 | 355 | 297 | 143 | 237 | 164 | 163 | 184 | 226 | 260 | 297 | 340 |
| Total Liabilities | 2,281 | 2,405 | 2,821 | 2,402 | 1,786 | 2,202 | 2,434 | 2,390 | 2,569 | 2,359 | 2,435 | 2,226 | 2,180 |
| Fixed Assets | 632 | 917 | 1,138 | 1,103 | 1,082 | 1,026 | 1,004 | 954 | 1,049 | 1,078 | 1,071 | 1,189 | 1,163 |
| CWIP | 268 | 22 | 15 | 34 | 4 | 24 | 90 | 145 | 61 | 22 | 112 | 11 | 16 |
| Investments | 0 | 0 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 100 |
| Other Assets | 1,381 | 1,466 | 1,667 | 1,263 | 699 | 1,151 | 1,340 | 1,291 | 1,458 | 1,257 | 1,249 | 1,022 | 902 |
| Total Assets | 2,281 | 2,405 | 2,821 | 2,402 | 1,786 | 2,202 | 2,434 | 2,390 | 2,569 | 2,359 | 2,435 | 2,226 | 2,180 |
Below is a detailed analysis of the balance sheet data for Bannari Amman Sugars Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,809.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,766.00 Cr. (Mar 2025) to 1,809.00 Cr., marking an increase of 43.00 Cr..
- For Borrowings, as of Sep 2025, the value is 19.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 150.00 Cr. (Mar 2025) to 19.00 Cr., marking a decrease of 131.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 340.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 297.00 Cr. (Mar 2025) to 340.00 Cr., marking an increase of 43.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,180.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,226.00 Cr. (Mar 2025) to 2,180.00 Cr., marking a decrease of 46.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,163.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,189.00 Cr. (Mar 2025) to 1,163.00 Cr., marking a decrease of 26.00 Cr..
- For CWIP, as of Sep 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 5.00 Cr..
- For Investments, as of Sep 2025, the value is 100.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 100.00 Cr., marking an increase of 96.00 Cr..
- For Other Assets, as of Sep 2025, the value is 902.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,022.00 Cr. (Mar 2025) to 902.00 Cr., marking a decrease of 120.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,180.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,226.00 Cr. (Mar 2025) to 2,180.00 Cr., marking a decrease of 46.00 Cr..
Notably, the Reserves (1,809.00 Cr.) exceed the Borrowings (19.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 147.00 | 127.00 | 203.00 | 347.00 | -297.00 | -587.00 | -765.00 | -661.00 | -743.00 | -277.00 | -180.00 | 60.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 23 | 16 | 33 | 24 | 17 | 42 | 43 | 38 | 63 | 20 | 22 | 14 |
| Inventory Days | 1,542 | 757 | 485 | 296 | 188 | 529 | 330 | 339 | 255 | 205 | 247 | 277 |
| Days Payable | 97 | 39 | 50 | 27 | 28 | 95 | 21 | 20 | 22 | 17 | 19 | 27 |
| Cash Conversion Cycle | 1,468 | 734 | 468 | 293 | 176 | 476 | 352 | 356 | 296 | 209 | 249 | 263 |
| Working Capital Days | 164 | 109 | 98 | 68 | 71 | 115 | 91 | 96 | 81 | 85 | 101 | 142 |
| ROCE % | 6% | 4% | 6% | 12% | 8% | 7% | 8% | 7% | 7% | 12% | 12% | 9% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 83.47 | 121.46 | 114.35 | 63.78 | 73.48 |
| Diluted EPS (Rs.) | 83.47 | 121.46 | 114.35 | 63.78 | 73.48 |
| Cash EPS (Rs.) | 130.13 | 167.38 | 173.39 | 117.90 | 125.89 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1418.60 | 1346.44 | 1237.58 | 1135.11 | 1081.43 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1418.60 | 1346.44 | 1237.58 | 1135.11 | 1081.43 |
| Dividend / Share (Rs.) | 12.50 | 12.50 | 12.50 | 10.00 | 10.00 |
| Revenue From Operations / Share (Rs.) | 1429.84 | 1770.63 | 2014.06 | 1593.41 | 1244.99 |
| PBDIT / Share (Rs.) | 188.64 | 249.69 | 273.99 | 176.24 | 175.12 |
| PBIT / Share (Rs.) | 141.98 | 203.76 | 214.95 | 122.13 | 122.71 |
| PBT / Share (Rs.) | 129.39 | 178.52 | 175.61 | 97.08 | 91.34 |
| Net Profit / Share (Rs.) | 83.47 | 121.46 | 114.35 | 63.78 | 73.48 |
| PBDIT Margin (%) | 13.19 | 14.10 | 13.60 | 11.06 | 14.06 |
| PBIT Margin (%) | 9.92 | 11.50 | 10.67 | 7.66 | 9.85 |
| PBT Margin (%) | 9.04 | 10.08 | 8.71 | 6.09 | 7.33 |
| Net Profit Margin (%) | 5.83 | 6.85 | 5.67 | 4.00 | 5.90 |
| Return on Networth / Equity (%) | 5.88 | 9.02 | 9.23 | 5.61 | 6.79 |
| Return on Capital Employeed (%) | 9.24 | 13.71 | 15.09 | 9.63 | 9.94 |
| Return On Assets (%) | 4.70 | 6.25 | 6.07 | 3.11 | 3.85 |
| Long Term Debt / Equity (X) | 0.00 | 0.03 | 0.10 | 0.08 | 0.12 |
| Total Debt / Equity (X) | 0.08 | 0.28 | 0.37 | 0.67 | 0.62 |
| Asset Turnover Ratio (%) | 0.76 | 0.92 | 1.03 | 0.80 | 0.64 |
| Current Ratio (X) | 3.33 | 2.09 | 2.04 | 1.46 | 1.49 |
| Quick Ratio (X) | 0.37 | 0.32 | 0.33 | 0.43 | 0.31 |
| Inventory Turnover Ratio (X) | 1.89 | 1.55 | 1.72 | 1.46 | 1.14 |
| Dividend Payout Ratio (NP) (%) | 14.97 | 10.29 | 8.74 | 15.67 | 13.60 |
| Dividend Payout Ratio (CP) (%) | 9.60 | 7.46 | 5.76 | 8.48 | 7.94 |
| Earning Retention Ratio (%) | 85.03 | 89.71 | 91.26 | 84.33 | 86.40 |
| Cash Earning Retention Ratio (%) | 90.40 | 92.54 | 94.24 | 91.52 | 92.06 |
| Interest Coverage Ratio (X) | 14.99 | 9.89 | 6.97 | 7.03 | 5.58 |
| Interest Coverage Ratio (Post Tax) (X) | 7.63 | 5.81 | 3.91 | 3.55 | 3.34 |
| Enterprise Value (Cr.) | 4862.64 | 3372.02 | 3986.56 | 4309.94 | 2808.96 |
| EV / Net Operating Revenue (X) | 2.71 | 1.52 | 1.58 | 2.16 | 1.80 |
| EV / EBITDA (X) | 20.56 | 10.77 | 11.60 | 19.50 | 12.79 |
| MarketCap / Net Operating Revenue (X) | 2.63 | 1.30 | 1.35 | 1.68 | 1.26 |
| Retention Ratios (%) | 85.02 | 89.70 | 91.25 | 84.32 | 86.39 |
| Price / BV (X) | 2.65 | 1.71 | 2.20 | 2.36 | 1.45 |
| Price / Net Operating Revenue (X) | 2.63 | 1.30 | 1.35 | 1.68 | 1.26 |
| EarningsYield | 0.02 | 0.05 | 0.04 | 0.02 | 0.04 |
After reviewing the key financial ratios for Bannari Amman Sugars Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 83.47. This value is within the healthy range. It has decreased from 121.46 (Mar 24) to 83.47, marking a decrease of 37.99.
- For Diluted EPS (Rs.), as of Mar 25, the value is 83.47. This value is within the healthy range. It has decreased from 121.46 (Mar 24) to 83.47, marking a decrease of 37.99.
- For Cash EPS (Rs.), as of Mar 25, the value is 130.13. This value is within the healthy range. It has decreased from 167.38 (Mar 24) to 130.13, marking a decrease of 37.25.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,418.60. It has increased from 1,346.44 (Mar 24) to 1,418.60, marking an increase of 72.16.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,418.60. It has increased from 1,346.44 (Mar 24) to 1,418.60, marking an increase of 72.16.
- For Dividend / Share (Rs.), as of Mar 25, the value is 12.50. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 12.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,429.84. It has decreased from 1,770.63 (Mar 24) to 1,429.84, marking a decrease of 340.79.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 188.64. This value is within the healthy range. It has decreased from 249.69 (Mar 24) to 188.64, marking a decrease of 61.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 141.98. This value is within the healthy range. It has decreased from 203.76 (Mar 24) to 141.98, marking a decrease of 61.78.
- For PBT / Share (Rs.), as of Mar 25, the value is 129.39. This value is within the healthy range. It has decreased from 178.52 (Mar 24) to 129.39, marking a decrease of 49.13.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 83.47. This value is within the healthy range. It has decreased from 121.46 (Mar 24) to 83.47, marking a decrease of 37.99.
- For PBDIT Margin (%), as of Mar 25, the value is 13.19. This value is within the healthy range. It has decreased from 14.10 (Mar 24) to 13.19, marking a decrease of 0.91.
- For PBIT Margin (%), as of Mar 25, the value is 9.92. This value is below the healthy minimum of 10. It has decreased from 11.50 (Mar 24) to 9.92, marking a decrease of 1.58.
- For PBT Margin (%), as of Mar 25, the value is 9.04. This value is below the healthy minimum of 10. It has decreased from 10.08 (Mar 24) to 9.04, marking a decrease of 1.04.
- For Net Profit Margin (%), as of Mar 25, the value is 5.83. This value is within the healthy range. It has decreased from 6.85 (Mar 24) to 5.83, marking a decrease of 1.02.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.88. This value is below the healthy minimum of 15. It has decreased from 9.02 (Mar 24) to 5.88, marking a decrease of 3.14.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.24. This value is below the healthy minimum of 10. It has decreased from 13.71 (Mar 24) to 9.24, marking a decrease of 4.47.
- For Return On Assets (%), as of Mar 25, the value is 4.70. This value is below the healthy minimum of 5. It has decreased from 6.25 (Mar 24) to 4.70, marking a decrease of 1.55.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.03 (Mar 24) to 0.00, marking a decrease of 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.08. This value is within the healthy range. It has decreased from 0.28 (Mar 24) to 0.08, marking a decrease of 0.20.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.76. It has decreased from 0.92 (Mar 24) to 0.76, marking a decrease of 0.16.
- For Current Ratio (X), as of Mar 25, the value is 3.33. This value exceeds the healthy maximum of 3. It has increased from 2.09 (Mar 24) to 3.33, marking an increase of 1.24.
- For Quick Ratio (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has increased from 0.32 (Mar 24) to 0.37, marking an increase of 0.05.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 4. It has increased from 1.55 (Mar 24) to 1.89, marking an increase of 0.34.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.97. This value is below the healthy minimum of 20. It has increased from 10.29 (Mar 24) to 14.97, marking an increase of 4.68.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 9.60. This value is below the healthy minimum of 20. It has increased from 7.46 (Mar 24) to 9.60, marking an increase of 2.14.
- For Earning Retention Ratio (%), as of Mar 25, the value is 85.03. This value exceeds the healthy maximum of 70. It has decreased from 89.71 (Mar 24) to 85.03, marking a decrease of 4.68.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 90.40. This value exceeds the healthy maximum of 70. It has decreased from 92.54 (Mar 24) to 90.40, marking a decrease of 2.14.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 14.99. This value is within the healthy range. It has increased from 9.89 (Mar 24) to 14.99, marking an increase of 5.10.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 7.63. This value is within the healthy range. It has increased from 5.81 (Mar 24) to 7.63, marking an increase of 1.82.
- For Enterprise Value (Cr.), as of Mar 25, the value is 4,862.64. It has increased from 3,372.02 (Mar 24) to 4,862.64, marking an increase of 1,490.62.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.71. This value is within the healthy range. It has increased from 1.52 (Mar 24) to 2.71, marking an increase of 1.19.
- For EV / EBITDA (X), as of Mar 25, the value is 20.56. This value exceeds the healthy maximum of 15. It has increased from 10.77 (Mar 24) to 20.56, marking an increase of 9.79.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.63. This value is within the healthy range. It has increased from 1.30 (Mar 24) to 2.63, marking an increase of 1.33.
- For Retention Ratios (%), as of Mar 25, the value is 85.02. This value exceeds the healthy maximum of 70. It has decreased from 89.70 (Mar 24) to 85.02, marking a decrease of 4.68.
- For Price / BV (X), as of Mar 25, the value is 2.65. This value is within the healthy range. It has increased from 1.71 (Mar 24) to 2.65, marking an increase of 0.94.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.63. This value is within the healthy range. It has increased from 1.30 (Mar 24) to 2.63, marking an increase of 1.33.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to 0.02, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bannari Amman Sugars Ltd:
- Net Profit Margin: 5.83%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.24% (Industry Average ROCE: 8.62%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.88% (Industry Average ROE: 7.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 7.63
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.37
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 37 (Industry average Stock P/E: 41.65)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.08
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.83%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Sugar | 1212, Trichy Road, Coimbatore Tamil Nadu 641018 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. S V Balasubramaniam | Chairman |
| Mr. B Saravanan | Managing Director |
| Dr. Radha Ramani | Ind. Non-Executive Woman Director |
| Mr. C Devarajan | Ind. Non-Executive Director |
| Mr. M Rathinasamy | Ind. Non-Executive Director |
| Mr. M Ponnuswami | Ind. Non-Executive Director |
| Mr. M Bharath Kumar | Non Exe.Non Ind.Director |
FAQ
What is the intrinsic value of Bannari Amman Sugars Ltd?
Bannari Amman Sugars Ltd's intrinsic value (as of 12 January 2026) is ₹2606.82 which is 27.59% lower the current market price of ₹3,600.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹4,515 Cr. market cap, FY2025-2026 high/low of ₹4,675/2,915, reserves of ₹1,809 Cr, and liabilities of ₹2,180 Cr.
What is the Market Cap of Bannari Amman Sugars Ltd?
The Market Cap of Bannari Amman Sugars Ltd is 4,515 Cr..
What is the current Stock Price of Bannari Amman Sugars Ltd as on 12 January 2026?
The current stock price of Bannari Amman Sugars Ltd as on 12 January 2026 is ₹3,600.
What is the High / Low of Bannari Amman Sugars Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bannari Amman Sugars Ltd stocks is ₹4,675/2,915.
What is the Stock P/E of Bannari Amman Sugars Ltd?
The Stock P/E of Bannari Amman Sugars Ltd is 37.0.
What is the Book Value of Bannari Amman Sugars Ltd?
The Book Value of Bannari Amman Sugars Ltd is 1,453.
What is the Dividend Yield of Bannari Amman Sugars Ltd?
The Dividend Yield of Bannari Amman Sugars Ltd is 0.35 %.
What is the ROCE of Bannari Amman Sugars Ltd?
The ROCE of Bannari Amman Sugars Ltd is 8.68 %.
What is the ROE of Bannari Amman Sugars Ltd?
The ROE of Bannari Amman Sugars Ltd is 6.04 %.
What is the Face Value of Bannari Amman Sugars Ltd?
The Face Value of Bannari Amman Sugars Ltd is 10.0.